☆ 4.3 Article

Desipramine improves depression-like behavior and working memory by up-regulating p-CREB in Alzheimer's disease associated mice

JOURNAL OF INTEGRATIVE NEUROSCIENCE (2016)

Journal

JOURNAL OF INTEGRATIVE NEUROSCIENCE

Volume 15, Issue 2, Pages 247-260

Publisher

IMR PRESS

DOI: 10.1142/S021963521650014X

Keywords

Desipramine; Amyloid beta protein; depression; working memory; p-CREB

Funding

National Science Foundation of China [31471080, 31271201]
College Student Innovation Project of Shanxi [2013127]
Fund Program for the Scientific Activities of Selected Returned Overseas Professionals in Shanxi Province
Shanxi Scholarship Council of China [2013-054]

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Abstract

Aggregation of amyloid beta protein (A beta) and progressive loss of memory are the main characteristics of Alzheimer's disease (AD). It is noteworthy that approximately 40% of AD patients have depressive symptom. The close correlation between cognitive deficits and mental depression suggests a possibility that antidepression treatment might be beneficial to cognitive improvement in AD. The present study, by using tail-suspension test (TST), forced swimming, alternative electro-stimulus Y maze test and immunohistochemistry, examined the neuro-protective effects of desipramine, a newer generation tricyclic antidepressants (TCA), and investigated its possible molecular mechanism. The results showed that: (1) intra-hippocampal injection of A beta(1-42) induced depression-like behavior and associative learning deficits in mice, with an increased mean immobility time in tail-suspension and forced swimming test and an increased mean error times in Y maze test; (2) after treatment with desipramine (10 mg/kg, i.p.), the average immobility time significantly decreased, from 101.60 +/- 8.37 s in A beta(1-42) group to 57.7 +/- 9.31 s in A beta(1-42) plus desipramine group (n = 10; p < 0.05) in TST and from 184.70 +/- 6.52 s to 144.13 +/- 8.63 s (n = 8 or 9, p < 0.05) in forced swimming test, respectively; the mean error times of mice in Y maze test also significantly decreased, from 6.50 +/- 2.95 in A beta(1-4) group to 4.90 +/- 3.11 in A beta(1-4) plus desipramine group (n = 10, p < 0.05); (3) desipramine administration significantly prevented against A beta(1-4)-induced down-regulation of phosphorylated cAMP response element binding protein (p-CREB) in the hippocampus. These results indicate that A beta(1-4) could concurrently mimic the depression-like behavior and working memory disorder in mice, while desipramine could effectively reverse both the deficits induced by A beta(1-4). The neuroprotection of desipramine may be involved in the up-regulation of p-CREB level in the hippocampus of mice.

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3

Not enough ratings

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Kaixin-San improves Aβ-induced synaptic plasticity inhibition by affecting the expression of regulation proteins associated with postsynaptic AMPAR expression

Bo Zhang, Meng-Lu Wang, Shu-Ming Huang, Yu Cui, Yan Li

Summary: This study investigated the mechanism by which Kaixin-San (KXS) mitigates the toxic effects of amyloid-beta protein (Aβ) by regulating the expression of postsynaptic AMPA receptors (AMPARs). The results showed that KXS effectively improved the learning and memory impairment caused by Aβ, and reversed the inhibition of hippocampal long-term potentiation (LTP) induced by Aβ. The expression levels of several accessory proteins associated with AMPAR expression were also altered by KXS. These findings provide novel insights into the mechanism underlying the neuroprotective effects of KXS against Aβ-induced memory impairment.

FRONTIERS IN PHARMACOLOGY (2023)